No Difference in CV Outcomes in Hospitalized vs Outpatients Receiving Omecamtiv Mecarbil - The Cardiology Advisor

A study was conducted to compare the effect of omecamtiv mecarbil in the hospital vs the outpatient setting for patients being treated for heart failure.

The use of omecamtiv mecarbil reduces the risk for cardiovascular (CV) death or a worsening heart failure (HF) event when initiated among both hospitalized patients and outpatients with heart failure… [+3570 chars]

full article...